Using Standardised Strengths of Unlicensed Liquid Medicines in Children

Tim Root, Assistant Head, Medicines Assurance, NHS Specialist Pharmacy Service, Specialist Pharmacy ServicePublished Last updated See all updates

A joint statement from the Neonatal and Paediatric Pharmacists' Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)

Non-SPS content · This content has not been generated nor formally reviewed by SPS

Non-SPS content is present where SPS believes that the content supports our end-users’ work, and is credible and trusted. Non-SPS content is posted in collaboration with the non-SPS author; however, it has not been generated nor formally reviewed by SPS

Recommendation

NPPG and RCPCH strongly recommend that when children require unlicensed liquid medications, they should receive the RCPCH- and NPPG- recommended strength, where one exists. There are currently 17 such recommended strengths, 16 of which are published in relevant drug monographs of the BNF for Children. Standardising the prescribed strengths of these medicines, will reduce the risk of errors being made in the doses given to children and prevent hospitalisation from accidental under- and overdoses.

The most recent version is available at the link below

Change history

  1. Link updated to reflect the December 2020 update to original document
  1. Published